Sona Nanotech
-
David Regan of Sona Nanotech provides an update on its agreement with Siva Therapeutics to develop cancer treating therapies
In this InvestorIntel interview, Sona Nanotech Inc.’s (CSE: SONA | OTCQB: SNANF) CEO David Regan provides Tracy Weslosky with…
-
Focused on a better future, Siva’s cancer tumor therapy system selects Sona’s gold nanorod for delivery
Today we are going to talk about a company that is making progress in the targeted treatment of…
-
David Regan of Sona Nanotech talks about developments in its unique gold nanorod technology
In this InvestorIntel interview with host Tracy Weslosky, Sona Nanotech Inc.’s (CSE: SONA | OTCQB: SNANF) CEO David…
-
David Regan of Sona Nanotech on bringing their rapid saliva Covid-19 test to the market
In a recent InvestorIntel interview, Tracy Weslosky spoke with David Regan, CEO of Sona Nanotech Inc. (CSE: SONA | OTCQB:…
-
Sona Nanotech’s gold nanorods improve cancer treatments
For virtually everyone on the planet, cancer is a four letter word. One has to have a pretty…
-
David Regan on Sona Nanotech’s rapid-result saliva based COVID-19 test
In a recent InvestorIntel interview, Chris Thompson spoke with David Regan, CEO of Sona Nanotech Inc. (CSE: SONA |…
-
Sona Nanotech is seeking U.S. FDA approval for its rapid COVID-19 saliva test
Much to my chagrin, it appears this damn COVID virus is refusing to let us be. I guess…
